DMPI - Kintara Therapeutics Inc

1.34
1.340   100.000%

Share volume: 0
Last Updated: 08-19-2020

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$1.34
P/E Ratio 
N/A
DAY RANGE
$1.34 - $1.34
EPS 
-$1.43
52 WEEK RANGE
$0.38 - $1.53
52 WEEK CHANGE
$74.27
MARKET CAP 
15.349 M
YIELD 
N/A
SHARES OUTSTANDING 
11.454 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$11,253,809
AVERAGE 10 VOLUME 
$1,708,179
AVERAGE 30 VOLUME 
$1,360,105
Company detail
CEO: Saiid Zarrabian
Region: US
Website: http://www.delmarpharma.com
Employees: 17
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry:
Sector:

DelMar Pharmaceuticals, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.

Recent news